secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2021-11-16T23:59:59+00:00
Accession:  0001493152-21-028944
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo annual meeting: directors elected, stock plan amended with 2M additional shares, auditor ratified
--------------------------------------------------------------------------------

- Stockholders elected three Class I directors: Joseph Lawler, Daniel Schneebeger, Aron English.
- Amendment to 2020 Stock Incentive Plan approved, increasing authorized shares by 2,000,000 to 3,650,000 (13.55M for, 69K against).
- Appointment of EisnerAmper LLP as independent auditor for FY2022 ratified (14,080,531 for, 0 against, 737 abstain).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000149315221028944/0001493152-21-028944-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000149315221028944/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-028944

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer